Clinical Trial Update: Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease have been posted; sponsor AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-08-23